搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Drosophila melanogaster Probable cytochrome P450 4ac3 (Cyp4ac3), partial CSB-YP894250DLU
CSB-EP894250DLU
CSB-BP894250DLU
CSB-MP894250DLU
CSB-EP894250DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Probable cytochrome P450 28d2 (Cyp28d2), partial CSB-YP894251DLU
CSB-EP894251DLU
CSB-BP894251DLU
CSB-MP894251DLU
CSB-EP894251DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Mannose-P-dolichol utilization defect 1 protein homolog (CG3792), partial CSB-YP894252DLU1
CSB-EP894252DLU1
CSB-BP894252DLU1
CSB-MP894252DLU1
CSB-EP894252DLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Contactin (Cont), partial CSB-YP894253DLU
CSB-EP894253DLU
CSB-BP894253DLU
CSB-MP894253DLU
CSB-EP894253DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Putative cysteine proteinase CG12163 (CG12163) CSB-YP894254DLU
CSB-EP894254DLU
CSB-BP894254DLU
CSB-MP894254DLU
CSB-EP894254DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Putative odorant receptor 83a (Or83a), partial CSB-YP894255DLU1
CSB-EP894255DLU1
CSB-BP894255DLU1
CSB-MP894255DLU1
CSB-EP894255DLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster 60S ribosomal protein L13a (RpL13A) CSB-YP894256DLU
CSB-EP894256DLU
CSB-BP894256DLU
CSB-MP894256DLU
CSB-EP894256DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster UPF0609 protein CG1218 (CG1218) CSB-YP894257DLU
CSB-EP894257DLU
CSB-BP894257DLU
CSB-MP894257DLU
CSB-EP894257DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster ATP-dependent RNA helicase Ddx1 (Ddx1), partial CSB-YP894258DLU
CSB-EP894258DLU
CSB-BP894258DLU
CSB-MP894258DLU
CSB-EP894258DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Cytosolic Fe-S cluster assembly factor NUBP2 homolog (CG4858) CSB-YP894259DLU
CSB-EP894259DLU
CSB-BP894259DLU
CSB-MP894259DLU
CSB-EP894259DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Gustatory and odorant receptor 21a (Gr21a), partial CSB-YP894260DLU1
CSB-EP894260DLU1
CSB-BP894260DLU1
CSB-MP894260DLU1
CSB-EP894260DLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Derlin-1 (Der-1), partial CSB-YP894261DLU1
CSB-EP894261DLU1
CSB-BP894261DLU1
CSB-MP894261DLU1
CSB-EP894261DLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Dual oxidase (Duox), partial CSB-YP894262DLU
CSB-EP894262DLU
CSB-BP894262DLU
CSB-MP894262DLU
CSB-EP894262DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Nicotinate phosphoribosyltransferase (CG3714), partial CSB-YP894263DLU
CSB-EP894263DLU
CSB-BP894263DLU
CSB-MP894263DLU
CSB-EP894263DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster RNA (guanine-9-)-methyltransferase domain-containing protein 2 homolog (CG14618) CSB-YP894264DLU
CSB-EP894264DLU
CSB-BP894264DLU
CSB-MP894264DLU
CSB-EP894264DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Probable E3 ubiquitin-protein ligase HERC2 (HERC2), partial CSB-YP894265DLU
CSB-EP894265DLU
CSB-BP894265DLU
CSB-MP894265DLU
CSB-EP894265DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Ubiquitin carboxyl-terminal hydrolase 36 (scny), partial CSB-YP894266DLU
CSB-EP894266DLU
CSB-BP894266DLU
CSB-MP894266DLU
CSB-EP894266DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Signal recognition particle 9 kDa protein (Srp9) CSB-YP894267DLU
CSB-EP894267DLU
CSB-BP894267DLU
CSB-MP894267DLU
CSB-EP894267DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Probable Bax inhibitor 1 (CG7188), partial CSB-YP894268DLU1
CSB-EP894268DLU1
CSB-BP894268DLU1
CSB-MP894268DLU1
CSB-EP894268DLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Alpha-tubulin N-acetyltransferase 1 (CG3967) CSB-YP894269DLU
CSB-EP894269DLU
CSB-BP894269DLU
CSB-MP894269DLU
CSB-EP894269DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>